Clinical Trial Update: SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of SNB-101 for extensive-stage small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• SNB-101

Snippet

Sponsor: SN BioScience | Conditions: Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC) | Phase 1, Phase 2 | Status: RECRUITING